LEADER 03353nam 2200553 450 001 9910787702703321 005 20230803195437.0 010 $a3-95489-698-2 035 $a(CKB)2670000000534309 035 $a(EBL)1640301 035 $a(SSID)ssj0001215256 035 $a(PQKBManifestationID)11772711 035 $a(PQKBTitleCode)TC0001215256 035 $a(PQKBWorkID)11191720 035 $a(PQKB)10652893 035 $a(MiAaPQ)EBC1640301 035 $a(Au-PeEL)EBL1640301 035 $a(CaPaEBR)ebr10856464 035 $a(OCoLC)871779539 035 $a(EXLCZ)992670000000534309 100 $a20140415h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCRO- contract research organization $ehow drug research is evolving /$fJakob Miera 210 1$aHamburg, Germany :$cAnchor Academic Publishing,$d2014. 210 4$dİ2014 215 $a1 online resource (91 p.) 300 $aDescription based upon print version of record. 311 $a3-95489-198-0 320 $aIncludes bibliographical references. 327 $aCRO - Contract Research Organization; Index; List of Figures; List of Tables; List of Abbreviations; Introduction; Methodology; 1. Merger & Acquisitions Fundamentals; 1.1 Definition and History; 1.2 Types and history of Merger & Acquisitions; 1.3 Recent M&A Trends; 2. Contract Research Organization Industry; 2.1 The Drug Development Process; 2.2 Fundamentals of Contract Research Organizations; 2.3 Strategic Analysis of the Drug Development Market; 2.4 Growth Strategies in CRO Industry; 3. Explanatory Approaches and Motives for M&A; 3.1 Strategic Motives; 3.2 Financial Motives 327 $a3.3 Managerial Motives4. Success Factors for the Merger & Acquisitions process; 4.1 Merger & Acquisitions Process; 4.2 Potential Success Factors during the M&A process; 5. Case Study: Merger & Acquisitions in the CRO industry; 5.1 Data & Methodology; 5.2 Why M&A occur in the CRO Industry; 5.3 Potential Success Factors for the M&A process in the CRO industry; 5.4 Reasons for success failures for the M&A process in the CRO industry; 5.5 Determinants and evaluation for success after the M&A; 6. Conclusion and Recommendations; Appendix; Bibliography 330 $aThis book deals in general with mergers and acquisitions in the CRO industry, and more specifically with reasons for M and A, success factors during the M and A process, and why M and A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than 800 million and lasting between 10 and 15 years. Due to these 606 $aPharmaceutical biotechnology$zGermany 606 $aBiopharmaceutics$xEconomic aspects 615 0$aPharmaceutical biotechnology 615 0$aBiopharmaceutics$xEconomic aspects. 676 $a615.19 700 $aMiera$b Jakob$01476313 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787702703321 996 $aCRO- contract research organization$93690888 997 $aUNINA